Genmab A/S said that Johnson & Johnson has decided not to exercise its option to obtain a worldwide license for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback